Recursion Pharmaceuticals, Inc. (RXRX)
2.96
-0.05
(-1.66%)
USD |
NASDAQ |
Jul 24, 16:00
2.98
+0.02
(+0.68%)
After-Hours: 20:00
Recursion Pharmaceuticals Price : 2.96 for July 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 24, 2026 | 3.04 | 3.09 | 2.92 | 2.96 | 16.53M |
| Jul 23, 2026 | 2.925 | 3.03 | 2.92 | 3.01 | 18.83M |
| Jul 22, 2026 | 3.04 | 3.07 | 2.97 | 2.98 | 15.21M |
| Jul 21, 2026 | 2.90 | 3.08 | 2.90 | 3.08 | 14.87M |
| Jul 20, 2026 | 2.945 | 2.955 | 2.84 | 2.89 | 20.81M |
| Jul 17, 2026 | 2.96 | 3.02 | 2.93 | 2.945 | 19.35M |
| Jul 16, 2026 | 3.25 | 3.27 | 2.975 | 3.02 | 40.17M |
| Jul 15, 2026 | 3.37 | 3.44 | 3.28 | 3.31 | 19.43M |
| Jul 14, 2026 | 3.29 | 3.38 | 3.205 | 3.34 | 25.66M |
| Jul 13, 2026 | 3.515 | 3.54 | 3.271 | 3.30 | 24.50M |
| Jul 10, 2026 | 3.80 | 3.80 | 3.44 | 3.56 | 20.81M |
| Jul 09, 2026 | 3.725 | 3.90 | 3.69 | 3.76 | 22.29M |
| Jul 08, 2026 | 3.72 | 3.808 | 3.63 | 3.72 | 22.71M |
| Jul 07, 2026 | 3.95 | 4.05 | 3.81 | 3.84 | 28.86M |
| Jul 06, 2026 | 3.78 | 4.09 | 3.66 | 3.96 | 38.07M |
| Jul 02, 2026 | 3.745 | 3.91 | 3.70 | 3.80 | 32.68M |
| Jul 01, 2026 | 3.65 | 4.04 | 3.61 | 3.67 | 35.73M |
| Jun 30, 2026 | 3.678 | 3.72 | 3.57 | 3.67 | 23.16M |
| Jun 29, 2026 | 3.615 | 3.74 | 3.55 | 3.69 | 22.93M |
| Jun 26, 2026 | 3.29 | 3.62 | 3.282 | 3.52 | 42.59M |
| Jun 25, 2026 | 3.24 | 3.38 | 3.19 | 3.34 | 15.63M |
| Jun 24, 2026 | 3.20 | 3.38 | 3.160 | 3.23 | 15.50M |
| Jun 23, 2026 | 3.095 | 3.27 | 3.09 | 3.16 | 11.17M |
| Jun 22, 2026 | 3.20 | 3.32 | 3.11 | 3.18 | 14.44M |
| Jun 18, 2026 | 3.18 | 3.28 | 3.11 | 3.23 | 24.85M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Twist Bioscience Corp. | 90.27 |
| Novavax, Inc. | 7.46 |
| Stoke Therapeutics, Inc. | 29.30 |
| Dyne Therapeutics, Inc. | 24.44 |
| Veracyte, Inc. | 56.61 |
Price Related Metrics
| PS Ratio | 21.40 |
| Price to Book Value | 1.533 |
| Earnings Yield | -40.61% |
| Market Cap | 1.571B |